In the first year of launch, more than a third of all drugs failed to meet market expectations. At the same time, 26% far exceeded expectations. How can pharma companies ensure launch success in today’s rapidly evolving scientific landscape?
Hear from Mark Rees-Saunders, Senior Director, Global Field Medical Excellence at Astellas, Véronique Gras, Associate Director Field Force Effectiveness at Bristol Myers Squibb, and Konstantinos Kofinas, Head of Business Innovation at Menarini, as they share how they are leveraging effective KOL engagement for a successful launch strategy.
Discover the impact of real-time customer intelligence for field teams.